ESG risk score 10.93
Environmental score 2.11
Social score 6.23
Governance score 2.59
ESG risk category Low
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Novartis AG
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol NOVN:xvtx
Currency CHF
SIX Swiss Exchange
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) 12.41%
1 year 27.25%
3 years 55.19%
Data provided by 
Key stats
Price/earnings (LTM) 20.53
Dividend yield (LTM) 3%
EPS (LTM) 6
Volatility (30 days) 22.92%
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Sector Healthcare
Industry -
Market cap 219bn
Data provided by /
/ Novartis AG (NOVN) is a Swiss multinational pharmaceutical company headquartered in Basel, Switzerland. Formed in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis is one of the world's largest healthcare companies, focused on innovative medicines.
The company's activities centre on research, development, manufacturing, and marketing of prescription medicines across therapeutic areas such as oncology, immunology, neuroscience, and cardiovascular/renal diseases.
With a global presence, Novartis invests heavily in biotechnology, advanced therapies, and digital health solutions. The group continues to expand its portfolio through innovation and strategic partnerships, addressing unmet medical needs worldwide.
Novartis AG is listed on the SIX Swiss Exchange.
Data provided by 
Saxo provides this content for general information only. It is not intended as personal advice, an offer, or a recommendation. Saxo does not guarantee accuracy or completeness and accepts no liability for losses. Consider obtaining independent advice before any investment decision.
Frequently asked questions
To buy Novartis AG stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Novartis AG by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Novartis AG is NOVN:xvtx. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Novartis AG has its primary listing on SIX Swiss Exchange. You can trade Novartis AG with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Novartis AG is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Novartis AG as part of a broader investment portfolio.